An Introduction to Testing for Drugs of Abuse. William E. Schreiber
Чтение книги онлайн.

Читать онлайн книгу An Introduction to Testing for Drugs of Abuse - William E. Schreiber страница 10

Название: An Introduction to Testing for Drugs of Abuse

Автор: William E. Schreiber

Издательство: John Wiley & Sons Limited

Жанр: Химия

Серия:

isbn: 9781119794073

isbn:

СКАЧАТЬ href="http://www.drugabuse.gov/publications/drugs-brains-behavior-science-addiction/introduction">www.drugabuse.gov/publications/drugs‐brains‐behavior‐science‐addiction/introduction

      Videos

      2‐Minute Neuroscience – Reward system. www.neuroscientificallychallenged.com/blog/2‐minute‐neuroscience‐reward‐system.

      AACC Pearls of Laboratory Medicine

      Drugs of abuse testing

      1 www.aacc.org/science‐and‐research/clinical‐chemistry‐trainee‐council/trainee‐council‐in‐english/pearls‐of‐laboratory‐medicine/2011/drugs‐of‐abuse‐testing.

      There are four steps in a drug's journey through the body: (i) absorption, (ii) distribution, (iii) metabolism, and (iv) excretion. These processes determine the time frame during which a drug can be detected in blood, urine, and other body fluids. They also determine the rate at which new compounds (i.e., metabolites) appear after a drug is taken. The study of drug absorption, distribution, metabolism, and excretion – what the body does to a drug – is called pharmacokinetics.

      Absorption is the process by which drug molecules enter the bloodstream. The rate of this process depends on the route of administration.

Oral When taken orally, a drug is absorbed across the mucosal lining of the stomach or small intestine before entering the blood. Onset of pharmacological effects typically occurs in 15–60 minutes, depending on the properties of the drug and its formulation (i.e., tablet vs liquid).
Following absorption, orally administered drugs are carried by the portal circulation directly to the liver, where they may be converted to less active metabolites before entering the systemic circulation. This “first‐pass” effect can limit the bioavailability of a drug.
Example: benzodiazepines
Intravenous Intravenous (IV) injection bypasses the absorption step, as the drug is introduced directly into the circulation. The IV route provides the fastest onset of drug action.
Example: heroin
Inhalation Air‐borne drug molecules are pulled into the lungs, cross alveolar walls (where gas exchange takes place) and diffuse into adjacent capillaries. This happens when a drug is smoked or inhaled as an aerosol. Onset of drug effects can be very rapid.
Example: cannabis
Insufflation Better known as “snorting,” insufflation causes drugs to contact nasal passages, which are lined by a mucous membrane. It is a more porous barrier than skin and allows rapid diffusion of drugs into underlying blood vessels.
Example: cocaine
Transdermal Diffusion across skin is a slow process. Drug patches are used to deliver a constant amount of drug per unit of time and maintain stable levels in blood.
Example: fentanyl

      Once a drug has entered the circulation, it is transported through the body and diffuses into tissues. This process is influenced by several factors.

       Blood flow – drugs are more rapidly distributed to areas of the body with a high rate of blood flow. For most drugs of abuse as well as many prescription medications, the main target organ is the brain, which is well perfused (15% of cardiac output in the resting state).

       Chemical structure – drugs that are lipophilic and are not ionized more readily cross lipid bilayers and enter cells.

       Protein binding – when bound to plasma proteins (mainly albumin), drugs cannot freely pass through capillary walls and enter tissues. The degree of plasma protein binding therefore affects the amount of drug that reaches its target.

      Drugs that are very lipid soluble may distribute into adipose tissue, accumulate there, and eventually diffuse back into the circulation. This can prolong the action of the drug, and it increases the length of time a drug or its metabolite(s) can be detected in blood or urine.

      The purpose of metabolism is to transform lipid‐soluble compounds, which readily enter tissues, into a more water‐soluble form that can be excreted. This occurs in two phases.

       Phase I – drug molecules are chemically altered by oxidation, reduction, or hydrolysis. These reactions are catalyzed by enzymes in the liver and, to a lesser extent, in other tissues. The most important drug‐metabolizing enzyme system, cytochrome P450 (CYP), contains multiple isoforms that act on a wide variety of drugs. The resulting products are usually inactive or less active than the parent drug. However, in some cases the metabolite has similar or even greater potency.

       Phase II – metabolites from phase I, or in some cases the unchanged drug, are conjugated to a water‐soluble group. This usually involves the addition of glucuronic acid or sulfate to an available –OH on the drug molecule (Figure 2.1). The reactions are catalyzed by UDP glucuronosyltransferase and sulfotransferase enzymes, respectively.

      The rate of metabolism varies among individuals. Genetic polymorphisms in CYP and other drug‐metabolizing СКАЧАТЬ